Tag: Valneva

April 14, 2022 Off

Valneva’s Inactivated Covid-19 Vaccine Gets CMA in UK

By Author

The Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom has granted Conditional Marketing Authorization (CMA) for Valneva’s inactivated whole-virus COVID-19 vaccine candidate, VLA2001, for primary immunization in adults 18 to 50 years of age.